EUVIMEDEUVIMED entdecken
Crossref

Effect of introducing ethambutol and integrating drugs into fixed-dose tablets on mortality in tuberculosis patients

Fredi Alexander Diaz-Quijano iD, Patricia Bartholomay, Kleydson Bonfim Andrade, Daniele Maria Pelissari, Denise Arakaki-Sanchez, Fernanda Dockhorn Costa, Rejane Sobrino Pinheiro

Transactions of The Royal Society of Tropical Medicine and Hygiene · 2026

DOI: 10.1093/trstmh/traf100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transactions of The Royal Society of Tropical Medicine and Hygiene, 2026. Verfasst von Fredi Alexander Diaz-Quijano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Laboratory of Causal Inference in Epidemiology - LINCE-USP, School of Public Health, University of São Paulo, São Paulo, …. Hauptthemen laut MEDLINE: Ethambutol, Antitubercular Agents, Isoniazid, Tuberculosis. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In response to increasing primary resistance to isoniazid, the Brazilian Ministry of Health modified the tuberculosis (TB) treatment regimen at the end of 2009. The changes included adding ethambutol to the intensive phase, using fixed-dose combination tablets and adjusting isoniazid and pyrazinamide dosages. This study aimed to estimate the effect of the regimen change on all-cause mortality and, secondarily, on TB-specific mortality, treatment success and loss to follow-up.

Methods

We analysed cohorts of individuals ≥10 y of age who initiated TB treatment before (n = 145 528) and after (n = 161 264) the regimen change. Data were obtained from the national notifiable disease and mortality information systems. Missing data were imputed and effects were estimated using multilevel logistic regression models with states as the clustering level. Covariates were selected using a directed acyclic graph.

Results

The regimen change was not associated with all-cause mortality (relative risk [RR] 1.01 [95% confidence interval {CI} 0.98 to 1.04]) or TB-specific mortality (RR 0.98 [95% CI 0.95 to 1.02]). The treatment success rate was lower, and loss to follow-up was higher during the modified regimen period compared with the previous one. However, sensitivity analyses suggest that changes in the handling of transfers and missing outcome data may partly explain these findings.

Conclusion

We concluded that the modified regimen did not adversely affect survival among TB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EthambutolAntitubercular AgentsIsoniazidTuberculosisPyrazinamideHumansMaleFemaleMiddle AgedAdultBrazilTabletsTreatment OutcomeAgedDrug Therapy, CombinationYoung AdultAdolescentDrug Combinations

Stichwörter der Autor:innen

causalitylost to follow-upmortalitytreatmenttuberculosis

Substanzen

EthambutolAntitubercular AgentsIsoniazidTabletsPyrazinamideDrug Combinations

Autor:innen und Institutionen

  • Department of Epidemiology, Laboratory of Causal Inference in Epidemiology - LINCE-USP, School of Public Health, University of São Paulo, São Paulo, SP 01246-904, Brazil.
  • Health and Environment Surveillance Secretariat, Ministry of Health, Brasília, DF 70719-040, Brazil.
  • Public Health Institute, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-598, Brazil.

ORCID-Profile: Fredi Alexander Diaz-Quijano

Förderung

  • National Council for Scientific and Technological Development

Zitieren

APA

Diaz-Quijano, F. A., Bartholomay, P., Andrade, K. B., Pelissari, D. M., Arakaki-Sanchez, D., Costa, F. D., & Pinheiro, R. S. (2026). Effect of introducing ethambutol and integrating drugs into fixed-dose tablets on mortality in tuberculosis patients. Transactions of The Royal Society of Tropical Medicine and Hygiene. https://doi.org/10.1093/trstmh/traf100

Vancouver

Diaz-Quijano FA, Bartholomay P, Andrade KB, Pelissari DM, Arakaki-Sanchez D, Costa FD, et al. Effect of introducing ethambutol and integrating drugs into fixed-dose tablets on mortality in tuberculosis patients. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2026. doi:10.1093/trstmh/traf100

BibTeX
@article{DiazQuijano2026,
  author = {Diaz-Quijano, Fredi Alexander and Bartholomay, Patricia and Andrade, Kleydson Bonfim and Pelissari, Daniele Maria and Arakaki-Sanchez, Denise and Costa, Fernanda Dockhorn and Pinheiro, Rejane Sobrino},
  title = {Effect of introducing ethambutol and integrating drugs into fixed-dose tablets on mortality in tuberculosis patients},
  journal = {Transactions of The Royal Society of Tropical Medicine and Hygiene},
  year = {2026},
  doi = {10.1093/trstmh/traf100}
}
Kostenlos starten →